Paxlovid COVID Rebound: No Evidence for More Treatment, Says CDC

(MedPage Today) -- No evidence exists to support an additional course of treatment in patients with COVID-19 who experience a recurrence in illness after taking nirmatrelvir/ritonavir (Paxlovid), the CDC said on Tuesday. In a Health Advisory...
Source: MedPage Today Public Health - Category: American Health Source Type: news